<DOC>
	<DOCNO>NCT00003792</DOCNO>
	<brief_summary>RATIONALE : Vaccines make person 's white blood cell melanoma cell may make body build immune response kill tumor cell . PURPOSE : Phase I trial study effectiveness vaccine therapy treat patient metastatic melanoma .</brief_summary>
	<brief_title>Vaccine Therapy Treating Patients With Metastatic Melanoma</brief_title>
	<detailed_description>OBJECTIVES : I . Determine safety tolerability antigen pulse dendritic cell therapy patient metastatic melanoma . II . Perform serial analysis T cell B cell function patient treatment . III . Determine objective response response duration patient treatment . OUTLINE : Patients receive filgrastim ( G-CSF ) subcutaneously ( SQ ) day 1-6 , undergo leukapheresis 2-3 day , begin day 6 . Mononuclear cell select CD34+ cell laboratory , make dendritic cell , pulse MART-1 , gp100 , tyrosinase , MAGE-3 peptides flu matrix . These antigen pulse dendritic cell ( ApDCs ) use vaccination . Prior vaccination , ApDCs mix MART-1 , gp100 , tyrosinase , MAGE-3 , flu matrix . Patients receive dendritic cell vaccine mixture SQ every 2 week 4 prim dos . Patients receive 4 boost vaccination SQ 2 month , 5 month , 9 month , 15 month follow last priming vaccination . Patients follow monthly 2 year . PROJECTED ACCRUAL : A total 28 patient accrue study .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven metastatic melanoma Measurable disease HLAA2 01 phenotype No active CNS hepatic metastasis PATIENT CHARACTERISTICS : Age : 18 80 Performance status : Karnofsky 80100 % Life expectancy : Not specify Hematopoietic : Normal CD4 CD8 T cell number flow cytometry Lactic dehydrogenase less 2 time normal Hepatic : No viral hepatitis Renal : Not specify Cardiovascular : No prior venous thrombosis , angina pectoris , congestive heart failure Pulmonary : No prior asthma Immunologic : Positive intradermal skin test mumps , histoplasmosis , streptokinase antigen Immunoglobulin level normal No prior autoimmune disease ( lupus erythematosus , rheumatoid arthritis , thyroiditis ) No allergy tetanus toxoid influenza vaccine No sensitivity E. coli drug preparation Other : Not pregnant nursing Fertile patient must use effective contraception HIV negative No active infection PRIOR CONCURRENT THERAPY : Biologic therapy : At least 4 week since prior interferon At least 8 week since prior interleukin2 Chemotherapy : No 3 prior course cytotoxic chemotherapy At least 8 week since prior chemotherapy Endocrine therapy : No concurrent corticosteroid Radiotherapy : Not specify Surgery : Not specify Other : No concurrent immunosuppressive agent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2006</verification_date>
	<keyword>stage IV melanoma</keyword>
	<keyword>recurrent melanoma</keyword>
</DOC>